BioLargo Board Member Jack Strommen Buys 92,593 Options Amid 44% Stock Decline: Insider Confidence Sparks Short‑Term Rally?
BioLargo insiders, led by Jack Strommen, bought 92,593 options—signaling confidence amid a 44 % price drop, PFAS tech prospects, and a volatile market.
3 minutes to read